Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
(
1 selected
)
Type
Guidance (771)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (771)
Apply filters
Showing 691 to 700 of 771
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer
TA212
15 December 2010
15 December 2010
Trastuzumab for the treatment of HER2-positive metastatic gastric cancer
TA208
24 November 2010
24 November 2010
Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours
TA209
24 November 2010
24 November 2010
Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours
TA86
27 October 2004
1 November 2010
Denosumab for the prevention of osteoporotic fractures in postmenopausal women
TA204
27 October 2010
27 October 2010
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)
TA206
27 October 2010
27 October 2010
Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)
TA207
27 October 2010
27 October 2010
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
TA200
22 September 2010
22 September 2010
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor
TA195
25 August 2010
25 August 2010
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis
TA199
25 August 2010
25 August 2010
Previous page
1
…
68
69
Current page
70
71
72
…
78
Page
70
of
78
Next page
Results per page
10
25
50
All
Back to top